The 51.9% drawdown and technicals confirm the stock is in post-crash stabilization, not recovery — and the bull ignored this entirely.

• Drawdown: 51.9% from $225.64 to $108.66
• Current price: $133.29
• Still 41% below peak
• IPO price: $135
• Aug 11 intraday high: $139.98
• Aug 11 close: $133.29
• Intraday reversal: $6.69 (roughly 4.8%)
• 50 SMA: $141.76 → price is 6% below
• 200 SMA: $141.76 → price is 6% below
• 10 EMA: $124.68 → price is barely 7% above
• Volume Aug 6: 255M shares
• Volume Aug 7: 242M shares
• Volume Aug 10: 170M shares

↩ rebuts: “The bull argued that 255M-242M-170M volume represents 'capitulation-reversal' and 'supply absorption' — but capitulation volumes mark bottoms, not breakouts, and the fundamentals report itself warns that 200M+ volume may reflect short squeezes or news-driven flows that reverse quickly.”

Q2's 'inflection' is one quarter against a trough, not a sustained trend — and the TTM numbers reveal ongoing losses.

• Q1 2026 revenue: $4.69B
• Q1 2026 EBIT: -$1.95B
• Q1 2026 EBITDA: -$1.16B
• TTM net income: -$8.89B
• TTM EPS: -$1.10
• TTM operating margin: -1.8%
• TTM net margin: -35.7%
• TTM free cash flow: approximately -$31B
• Gross margin Q2: 55.3%
• Gross margin Q1: 49.1%
• Full-year gross margin: 49.4%
• Revenue growth QoQ: +66%
• Non-cash or one-time charge: ~$5-7B (likely related to mark-to-market, warrant revaluation, or write-downs)

↩ rebuts: “The bull cited Q2's EBIT flip and +66% QoQ revenue growth as proof of generational inflection — but Q1 was a disaster, making any reasonable quarter look like an inflection against a trough. Annual gross margins are oscillating, not trending linearly, and the 55.3% Q2 margin came after 49.1% in Q1 and 49.4% full-year. The easy gains from first-stage reuse are largely captured; future margin expansion will be harder, slower, and more contested.”

The forward EPS estimate of $1.85 is a consensus analyst estimate that has a high probability of being revised downward 15-20% post-IPO.

• Forward EPS estimate: $1.85
• Forward P/E: 71.94x
• Bear's estimate of consensus downward revision: 15-20% in first four quarters post-IPO

↩ rebuts: “The bull anchored the entire valuation thesis on forward EPS of $1.85 — but consensus estimates on freshly public hyper-growth names are revised downward an average of 15-20% in the first four quarters post-IPO. PEG works for profitable companies, not for unprofitable hyper-growth names where the correct framework is EV/Revenue and EV/EBITDA vs. growth-adjusted peers.”

The valuation is extreme at 71.9x forward P/E and ~76x P/S for an industrial with deeply negative FCF — multiples will compress in a higher-for-longer rate environment.

• Forward P/E: 71.94x (vs S&P ~21x)
• P/B: 13.80x
• Price/Sales (TTM): ~76x
• TTM EPS: -$1.10
• TTM FCF: approximately -$31B (equals ~37% of market cap annually)
• Stock-based comp: ~$3B run-rate (13% of revenue, ~10% of market cap per year)
• Bear's implied compressed multiple: ~50-55x
• Bear's estimated downside from multiple compression alone: ~25-30%

↩ rebuts: “The bull argued 71.9 / 33 = 2.18 PEG — but PEG works for profitable companies. SPCX is being priced like a SaaS leader while operating as a capital-intensive industrial with deeply negative FCF. Snowflake, CrowdStrike, and Datadog — actual category leaders with 30%+ growth and positive FCF — trade at 12-20x P/S. SPCX at ~76x P/S is rich even by growth-tech standards.”

The macro overlay (hawkish Fed, no cuts in 2026, Iran/Hormuz risk-off, July CPI print) creates an environment where high-beta, unprofitable story stocks get decapitated — the bull dismissed this as 'already priced in.'

• Fed funds probability of no cuts in 2026: 86%
• Bear's description of macro environment: hawkish Fed + oil shock + CPI week
• Bear's argument: higher discount rates = lower present value for long-duration growth assets

↩ rebuts: “The bull argued that SPCX's cost of capital is set by corporate bond markets, not Fed funds — true for solvency, but completely false for valuation. Long-duration growth assets are valued by discounting future cash flows, and 71.9x forward P/E requires a low terminal discount rate. If rates stay higher-for-longer, the multiple compresses.”

The three bull catalysts are narrative, not revenue: an FCC letter is regulatory positioning, a single-vendor data center bet is concentration risk, and Starlink 'in every car' is a tweet and aspiration.

• Catalyst 1: Aug 10 FCC letter — Bear says 'regulatory positioning, not revenue'
• Catalyst 2: NVIDIA-exclusive data center — Bear says 'single-vendor AI infrastructure bet is concentration risk'
• Catalyst 3: Starlink in every car — Bear says 'tweet and aspiration, not a contract'

↩ rebuts: “The bull called the FCC letter a 'regulatory moat event,' the data center 'differentiated, exclusive, and binary-bullish,' and Starlink 'TAM expansion.' The bear counters that NN rallied 24% as a small, beaten-down name with high short interest — SPCX did not rally on this news. 'Binary' means binary risk, not bullish. 'Will be in every car' ≠ 'is in every car' and 'billions of vehicles' ≠ 'any signed OEM agreement.'”

The 900M-share dilution is a one-time liquidity event, not permanent balance sheet improvement, and lockup expirations are coming — another equity raise is mathematically likely within 12-18 months given $16.8B quarterly FCF burn.

• 900M new shares dilution
• Total debt: $39.7B
• Preferred dropped from $38.75B to $0
• Q2 FCF burn: $16.8B
• Bear's claim: 'If capex stays elevated, another equity event is mathematically likely within 12-18 months'

↩ rebuts: “The bull argued the stock 'absorbed 900M new shares without breaking the trend' as evidence of supply absorption. The bear reframes: if the 900M shares came from insiders/private holders cashing out, that's distribution to retail at higher prices — which precedes weakness 3-6 months later. The $86B raise against $39.7B debt suggests some equity was used to pay down obligations or facilitate preferred-to-common conversion, a one-time event not a permanent improvement.”

The competitive landscape is tightening with Rocket Lab (Neutron targeting 2026-2027), Blue Origin (New Glenn operational, $20B+ annual funding capacity), and AST SpaceMobile (direct D2C competitor that just missed Q2 but improving).

• AST SpaceMobile Q2 revenue: $31.5M vs $35.18M expected
• Bear's characterization: 'The sector is wobbling, not rallying'
• Rocket Lab Neutron targeting: 2026-2027 deployment
• Blue Origin New Glenn: operational and signing national security launches
• Blue Origin annual funding capacity: $20B+
• Preferred dropped: from $38.75B to $0